Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension.
Segura-Ibarra V, Amione-Guerra J, Cruz-Solbes AS, Cara FE, Iruegas-Nunez DA, Wu S, Youker KA, Bhimaraj A, Torre-Amione G, Ferrari M, Karmouty-Quintana H, Guha A, Blanco E.
Segura-Ibarra V, et al. Among authors: ferrari m.
Int J Pharm. 2017 May 30;524(1-2):257-267. doi: 10.1016/j.ijpharm.2017.03.069. Epub 2017 Mar 28.
Int J Pharm. 2017.
PMID: 28359821